Shalimar, Sonika U, Kedia S, Mahapatra SJ, Nayak B, Yadav DP, Gunjan D, Thakur B, Kaur H, Acharya K

Language: English
References: 24
Page: 403-412
PDF size: 175.67 Kb.

ABSTRACT

Introduction and aim. Multiple prognostic scores are available for acute liver failure (ALF). Our objective was to compare the dynamicity of model for end stage liver disease (MELD), MELD-sodium, acute liver failure early dynamic model (ALFED), chronic liver failure (CLIF)-consortium ACLF score and King's College Hospital Criteria (KCH) for predicting outcome in ALF. Materials and methods. All consecutive patients with ALF at a tertiary care centre in India were included. MELD, MELD-Na, ALFED, CLIF-C ACLF scores and KCH criteria were calculated at admission and day 3 of admission. Area under receiver operator characteristic curves (AUROC) were compared with DeLong method. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), likelihood ratio (LR) and diagnostic accuracy (DA) were reported. Results. Of the 115 patients included in the study, 73 (63.5%) died. The discrimination of mortality with baseline values of prognostic scores (MELD, MELD-Na, ALFED, CLIF-C ACLF and KCH) was modest (AUROC: 0.65-0.77). The AUROC increased on day 3 for all scores, except KCH criteria. On day 3 of admission, ALFED score had the highest AUROC 0.95, followed by CLIF-C ACLF 0.88, MELD 0.81, MELD-Na 0.77 and KCH 0.52. The AUROC for ALFED was significantly higher than MELD, MELD-Na and KCH (P ‹ 0.001 for all) and CLIF-C ACLF (P = 0.05). ALFED score ≥ 4 on day 3 had the best sensitivity (87.1%), specificity (89.5%), PPV (93.8%), NPV (79.1%), LR positive (8.3) and DA (87.9%) for predicting mortality. Conclusions. Dynamic assessment of prognostic scores better predicts outcome. ALFED model performs better than MELD, MELD, MELD-Na, CLIF-C ACLF scores and KCH criteria for predicting outcome in viral hepatitis- related ALF.

REFERENCES

1. Acharya SK, Panda SK, Saxena A, Gupta SD. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol 2000; 15: 473-9. [PMID:10847431] 2, Shalimar, Acharya SK. Management in acute liver failure. J Clin Exp Hepatol 2015; 5: S104-115. [PMID: 26041950]

2. Polson J, Lee WM. AASLD position paper: The management of acute liver failure. Hepatology 2005; 41: 1179-97. [PMID: 15841455]

3. Fontana RJ, Ellerbe C, Durkalski VE, Rangnekar A, Reddy RK, Stravitz T, McGuire B, et al. Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver International 2015; 35: 370-80. [PMID: 25039930]

4. Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single- center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology 2008; 48: 1577-85. [PMID:18925633]

5. Kumar R, Shalimar, Bhatia V, Khanal S, Sreenivas V, Gupta SD, Panda SK, et al. Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. Hepatology 2010; 51: 1665-74. [PMID: 20196116]

6. Acharya SK, Dasarathy S, Kumer TL, Sushma S, Prasanna KS, Tandon A, Sreenivas V, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996; 23: 1448-55. [PMID: 8675163]

7. Kumar R, Shalimar, Sharma H, Praksh S, Panda SK, Khanal S, Acharya SK, et al. Persistent Hyperammonemia Is Associated with Complications and Poor Outcomes in Patients with Acute Liver Failure. Clin Gastroenterol Hepatology 2012; 10: 925-31 [PMID:22521861]

8. Jepsen P, Schmidt LE, Larsen FS, Vilstrup H. Long-term prognosis for transplant-free survivors of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 2010; 32: 894-900. [PMID: 20735774]

9. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45. [PMID: 2490426]

10. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71. [PMID: 10733541]

11. Kumar R, Shalimar, Sharma H, Goyal R, Kumar A, Khanal S, Prakash S, et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut 2012; 61:1068-75. [PMID: 22337947]

12. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26. [PMID:18768945]

13. Cholongitas E, Theocharidou E, Vasianopoulou P, Betrosian A, Shaw S, Patch D, O'Beirne J, et al. Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transplant 2012; 18: 405-12.[PMID 22213443]

14. Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014; 61: 1038-47. [PMID:24950482]

15. McPhail MJW, Wendon JA, Bernal W. Meta-analysis of performance of Kings's College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol 2010; 53: 492-9. [PMID:20580460]

16. Manka P, Bechmann LP, Tacke F, Sowa JP, Schlattjan M, Kälsch J, Jochum C, et al. Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure. BMC Gastroenterol 2013; 13: 58. [PMID:23551795]

17. Bernal W, Wang Y, Maggs J, Willars C, Sizer E, Auzinger G, Murphy N, et al. Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study. Lancet Gastroenterol Hepatol 2016; 1: 217-25. [PMID:28404094]

18. Tandon BN, Bernauau J, O'Grady J, Gupta SD, Krisch RE, Liaw YF, Okuda K, et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol 1999; 14: 403-4. [PMID:10355501]

19. Riegler JL, Lake JR. Fulminant hepatic failure. Med Clin North Am 1993; 77: 1057-83. [PMID:8371615]

20. Shalimar, Subrat K Acharya, William M Lee. Worldwide differences in acute liver failure. In: Critical Care in Acute Liver Failure [Internet]. Future Medicine Ltd; 2013 [cited 2016 May 14]. p. 32-46. Available from: http://www.futuremedicine. com/doi/abs/10.2217/ebo.12.326

21. Shalimar, Kedia S, Gunjan D, Sonika U, Mahapatra SJ, Nayak B, Kaur H, et al. Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients. Dig Dis Sci 2017; 62: 1058-66. [PMID: 28130708]

22. Louvet A, Labreuche J, Artru F, Boursier J, Kim DJ, O'Grady J, Trépo E, et al. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis. Gastroenterology 2015; 149: 398-406. [PMID:25935634]

23. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144:1426-37, 1437-9. [PMID:23474284]

24. Shalimar, Kumar D, Vadiraja PK, Nayak B, Thakur B, Das P, Datta Gupta S, et al. Acute on chronic liver failure because of acute hepatic insults: Etiologies, course, extrahepatic organ failure and predictors of mortality. J Gastroenterol Hepatol 2016; 31: 856-64. [PMID:26519215]